Life Sciences
Enabling Value Based CareA fundamental shift in health benchmarks towards value-based care and patient-centricity has disrupted the Life Sciences industry. These increased expectations have eventually resulted in innovator companies reevaluating development programs, innovate business models, adopt new technologies, redefine reimbursement strategy and clinical pipeline approach. Accommodating these disruptions is challenging and that can be achieved through improved R&D productivity, accelerated R&D and product development, and building partnerships throughout the value chain.
FutureBridge enables these aspirations of Life Sciences innovators by providing actionable techno-commercial insights derived from its customized intelligence programs that are backed by scientific proof, sentiments of key opinion leaders, and voice of the industry.
Gene Editing – Beyond CRISPR
#upcoming webinar – 21 Oct’21
Gene editing techniques have witnessed significant traction since CRISPR / CaS9 was discovered. Despite limitations, there was a multi-fold interest in the research community to capitalize CRISPR/ CaS9 tool in editing targeted gene sequences. In recent times, technologies such as TALEN, ZFN, NgAgO, Lambda Red had emerged as novel gene-editing tools having wider applicability with sequence specificity. How will this penetration evolve in the next few years across different therapy areas?
Gene Editing-Beyond CRISPR
#upcoming webinar – 21 Oct’21
Gene editing techniques have witnessed significant traction since CRISPR / CaS9 was discovered. Despite limitations, there was a multi-fold interest in the research community to capitalize CRISPR/ CaS9 tool in editing targeted gene sequences. In recent times, technologies such as TALEN, ZFN, NgAgO, Lambda Red had emerged as novel gene-editing tools having wider applicability with sequence specificity. How will this penetration evolve in the next few years across different therapy areas?
Strategic Growth Fields
A convergence of industry transformations and exponential technologies creates a pool of opportunities
Paradigm Shift in
R&D
- Shared risks & costs
- Virtual clinical trials & remote R&D
- Portfolio optimization & LCM
- Naturals & Alternatives
Personalization &
Precision
- Theragnostics
- Gene & cell therapy
- Targeted drug delivery
- Minimally invasive surgery (MIS)
Preventive Care & Predictive Diagnostics
- Prophylactic care & vaccination
- Early screening & rapid diagnosis
- Real-time monitoring & treatment
- Therapeutic nutrition
Evolving
Ecosystem
- Value-based care
- Home care
- Patient Centricity & patient partnership
- Wellness & self-care
- Sustainability 85%
- Digitalization 94%
- Business Model Innovation 87%
- Synthetic Biology 92%
- Big Data & Clinical Algorithms 85%
Industry Participants
Our Solutions
Our solutions combine a unique blend of research, consulting, and hyper-intelligence industry & technology platforms for deep insights
With our techno-commercial acumen, we unearth growth opportunities, connect technologies with markets and deliver business impact
The Business Functions for Whom We Create Value
The Business Functions for Whom We Create Value
Diverse technological advancements will define the future of connected mobility
